Could a single injection ease vaginal dryness? new trial tests hyaluronic acid gel

NCT ID NCT07701863

Not yet recruiting Symptom relief Sponsor: Biovico Sp. z o.o. Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This trial tests F-GYN, a single-use injectable gel made of non-crosslinked hyaluronic acid, for women with moderate to severe vaginal dryness and atrophy. Participants either receive the injection right away or continue standard non-hormonal care for 4 weeks before getting the injection. The study measures changes in vaginal health, dryness, itching, burning, pain during sex, and quality of life over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: F-GYN, a sterile injectable gel containing non-crosslinked hyaluronic acid, injected into vaginal and vestibular tissue
What this could lead to: If effective, F-GYN could offer a non-hormonal, injection-based option for women with persistent vaginal dryness and discomfort.
What could go wrong: This is a small, early-stage study comparing a single injection to standard care over just 4 weeks. Long-term safety and effectiveness are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATROPHIC VAGINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

postmenopausal atrophic vaginitis psychologic dyspareunia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATROPHIC VAGINITIS ATROPHIC VULVOVAGINITIS DYSPAREUNIA VAGINAL ATROPHY VAGINAL DRYNESS VULVO VAGINAL ATROPHY

More trials for these conditions

Other studies related to the condition(s) this trial covers.